[go: up one dir, main page]

AU2001251013A1 - Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer - Google Patents

Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer

Info

Publication number
AU2001251013A1
AU2001251013A1 AU2001251013A AU5101301A AU2001251013A1 AU 2001251013 A1 AU2001251013 A1 AU 2001251013A1 AU 2001251013 A AU2001251013 A AU 2001251013A AU 5101301 A AU5101301 A AU 5101301A AU 2001251013 A1 AU2001251013 A1 AU 2001251013A1
Authority
AU
Australia
Prior art keywords
staging
diagnosing
imaging
compositions
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251013A
Inventor
Ping Hu
Roberto A. Macina
Alejandra Piderit
Herve Recipon
Fei Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of AU2001251013A1 publication Critical patent/AU2001251013A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001251013A 2000-03-28 2001-03-26 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer Abandoned AU2001251013A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19266700P 2000-03-28 2000-03-28
US60192667 2000-03-28
PCT/US2001/009737 WO2001073030A2 (en) 2000-03-28 2001-03-26 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer

Publications (1)

Publication Number Publication Date
AU2001251013A1 true AU2001251013A1 (en) 2001-10-08

Family

ID=22710575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251013A Abandoned AU2001251013A1 (en) 2000-03-28 2001-03-26 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer

Country Status (3)

Country Link
US (1) US20020065396A1 (en)
AU (1) AU2001251013A1 (en)
WO (1) WO2001073030A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053304A1 (en) 2002-06-05 2004-03-18 Case Western Reserve University Methods and compositions for detecting cancers
WO2004040298A2 (en) * 2002-11-01 2004-05-13 Europroteome Ag Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment
EP2290066B1 (en) * 2004-05-28 2015-03-18 Asuragen, Inc. Methods and compositions involving microRNA
EP2302056B1 (en) 2004-11-12 2015-01-07 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
EP2115138A2 (en) * 2006-09-19 2009-11-11 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
AU2007299748A1 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. miR-15, miR-26, miR -31,miR -145, miR-147, miR-188, miR-215, miR-216 miR-331, mmu-miR-292-3p regulated genes and pathways as targets for therapeutic intervention
WO2008073920A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
WO2008073915A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
AU2007333109A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro RNAs
CA2671270A1 (en) * 2006-12-29 2008-07-17 Asuragen, Inc. Mir-16 regulated genes and pathways as targets for therapeutic intervention
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
CA2689974A1 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. Mir-34 regulated genes and pathways as targets for therapeutic intervention
EP2198050A1 (en) 2007-09-14 2010-06-23 Asuragen, INC. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009052386A1 (en) * 2007-10-18 2009-04-23 Asuragen, Inc. Micrornas differentially expressed in lung diseases and uses thereof
US8071562B2 (en) * 2007-12-01 2011-12-06 Mirna Therapeutics, Inc. MiR-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
US20090263803A1 (en) * 2008-02-08 2009-10-22 Sylvie Beaudenon Mirnas differentially expressed in lymph nodes from cancer patients
EP2268832A2 (en) * 2008-03-06 2011-01-05 Asuragen, INC. Microrna markers for recurrence of colorectal cancer
US20090253780A1 (en) * 2008-03-26 2009-10-08 Fumitaka Takeshita COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
WO2009137807A2 (en) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
US20100179213A1 (en) * 2008-11-11 2010-07-15 Mirna Therapeutics, Inc. Methods and Compositions Involving miRNAs In Cancer Stem Cells
CA2837393A1 (en) 2011-05-27 2012-12-06 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
PL3513806T3 (en) 2012-12-05 2023-05-15 Glaxosmithkline Biologicals Sa Immunogenic composition
EP3636278A3 (en) 2014-06-25 2020-07-15 GlaxoSmithKline Biologicals S.A. Clostridium difficile immunogenic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996857B1 (en) * 1997-07-17 2009-09-09 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer
WO2000007632A1 (en) * 1998-08-04 2000-02-17 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer

Also Published As

Publication number Publication date
WO2001073030A2 (en) 2001-10-04
US20020065396A1 (en) 2002-05-30
WO2001073030A3 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001250932A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1239874A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2002215345A1 (en) Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1317669A4 (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
EP1131095A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2001249431A1 (en) Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1107798A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
AU2002222944A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU6523901A (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer